Alpine Global Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,000
Closed -$697K 272
2023
Q2
$697K Buy
+15,000
New +$518K 0.19% 66

Alpine Global Management's DICE Position: Q3 2023 in Review

Alpine Global Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 15,000 shares — an estimated $697K sold.

Alpine Global Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $697K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Alpine Global Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Alpine Global Management sold 15,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $697K.
  • Alpine Global Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Alpine Global Management's DICE Therapeutics, Inc. Common Stock position peaked at $697K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Alpine Global Management's 13F filing for Q3 2023, filed 14 Nov 2023.